文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

ICU临床轨迹与结局的多状态建模:COVID-19危重患者急性肾损伤的概念验证评估

Multistate Modeling of Clinical Trajectories and Outcomes in the ICU: A Proof-of-Concept Evaluation of Acute Kidney Injury Among Critically Ill Patients With COVID-19.
PubMed 文献 · Crit Care Explor · 2022-12-01
一句话结论多状态分析显示COVID-19危重患者AKI发生早且异质,入住ICU 24小时后近半数(44.9%)已发生AKI,3期AKI 7天恢复率仅30.0%。

该回顾性队列研究纳入美国一家城市三级学术医院2020年收治的367例COVID-19 ICU患者(≥18岁,排除既往终末期肾病),以12小时为时间窗判定AKI存在与分期,并拟合多状态模型分析纵向转归。241例(66%)发生AKI,其中1期88例、2期49例、3期104例(51例接受RRT、53例未接受)。接受RRT者侵入性机械通气比例(95%)与死亡率(57%)均高于AKI未RRT组(53%、40%)和无AKI组(32%、19%)(p<0.001)。入住ICU 24小时后44.9%(95%CI 41.6-48.2%)已发生AKI;1期AKI后7天74.0%无AKI或出院,而3期AKI后7天恢复者仅30.0%、出院者仅7.9%。作者认为多状态方法在ICU服务科学中是有用且未被充分利用的工具。

要点

  • 367例COVID-19 ICU患者中241例(66%)发生AKI,最大分期为1期88例、2期49例、3期104例。
  • 入住ICU 24小时后44.9%(95%CI 41.6-48.2%)已发生AKI,提示AKI发生早。
  • 1期AKI后7天74.0%(95%CI 63.6-84.4)无AKI或出院;3期AKI后7天恢复30.0%(24.1-35.8%)、出院7.9%(5.2-10.7%)。
  • 接受RRT者侵入性机械通气95%、死亡57%,高于AKI未RRT组(53%、40%)和无AKI组(32%、19%),p<0.001。
  • 入住ICU 24小时后,接受与未接受IMV者早期AKI频率相似:AKI+IMV 20.9%(18.3-23.6%),AKI无IMV 23.4%(20.6-26.2%)。

适用人群与场景

  • 美国一家城市三级学术医院2020年收治的COVID-19 ICU患者,年龄≥18岁。
  • 排除既往终末期肾病患者。

诊断标准与关键阈值

  • 以12小时为离散时间窗判定AKI存在与分期。

研究设计与关键结果

  • 研究类型:回顾性队列研究,单家城市三级学术医院,367例次ICU收治。
  • AKI发生241例(66%),最大分期:1期88例、2期49例、3期104例;3期AKI中51例接受RRT、53例未接受。
  • 接受RRT者侵入性机械通气60例(95%),AKI未RRT组98例(53%),无AKI组39例(32%),p<0.001;死亡分别为36例(57%)、74例(40%)、23例(19%),p<0.001。
  • 入住ICU 24小时后44.9%(95%CI 41.6-48.2%)发生AKI。
  • 1期AKI后7天74.0%(95%CI 63.6-84.4)无AKI或出院;3期AKI后7天恢复30.0%(95%CI 24.1-35.8)、出院7.9%(95%CI 5.2-10.7)。
  • 入住ICU 24小时后,AKI+IMV为20.9%(95%CI 18.3-23.6),AKI无IMV为23.4%(95%CI 20.6-26.2)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(概念验证评估)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为多状态方法可用于理解ICU患者的临床轨迹、预后和资源需求,是ICU服务科学中有用且未被充分利用的工具。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Multistate models yield high-fidelity analyses of the dynamic state transition and temporal dimensions of a clinical condition's natural history, offering superiority over aggregate modeling techniques for addressing these types of problems.

OBJECTIVES: To demonstrate the utility of these models in critical care, we examined acute kidney injury (AKI) development, progression, and outcomes in COVID-19 critical illness through multistate analyses.

DESIGN SETTING AND PARTICIPANTS: Retrospective cohort study at an urban tertiary-care academic hospital in the United States. All patients greater than or equal to 18 years in an ICU with COVID-19 in 2020, excluding patients with preexisting end-stage renal disease.

MAIN OUTCOMES AND MEASURES: Using electronic health record data, we determined AKI presence/stage in discrete 12-hour time windows and fit multistate models to determine longitudinal transitions and outcomes.

RESULTS: Of 367 encounters, 241 (66%) experienced AKI (maximal stages: 88 stage-1, 49 stage-2, 104 stage-3 AKI [51 received renal replacement therapy (RRT), 53 did not]). Patients receiving RRT overwhelmingly received invasive mechanical ventilation (IMV) (n = 60, 95%) compared with the AKI-without-RRT (n = 98, 53%) and no-AKI groups (n = 39, 32%; p < 0.001), with similar mortality patterns (RRT: n = 36, 57%; AKI: n = 74, 40%; non-AKI: n = 23, 19%; p < 0.001). After 24 hours in the ICU, almost half the cohort had AKI (44.9%; 95% CI, 41.6-48.2%). At 7 days after stage-1 AKI, 74.0% (63.6-84.4) were AKI-free or discharged. By contrast, fewer patients experiencing stage-3 AKI were recovered (30.0% [24.1-35.8%]) or discharged (7.9% [5.2-10.7%]) after 7 days. Early AKI occurred with similar frequency in patients receiving and not receiving IMV: after 24 hours in the ICU, 20.9% of patients (18.3-23.6%) had AKI and IMV, while 23.4% (20.6-26.2%) had AKI without IMV.

CONCLUSIONS AND RELEVANCE: In a multistate analysis of critically ill patients with COVID-19, AKI occurred early and heterogeneously in the course of critical illness. Multistate methods are useful and underused in ICU care delivery science as tools for understanding trajectories, prognoses, and resource needs.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Lyons PG, Mody A, Bewley AF, et al. Multistate Modeling of Clinical Trajectories and Outcomes in the ICU: A Proof-of-Concept Evaluation of Acute Kidney Injury Among Critically Ill Patients With COVID-19. Crit Care Explor. 2022. PMID: 36479445. doi:10.1097/CCE.0000000000000784

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。